"All recommendations concerning the safety of gadolinium-based contrast agents, particularly in patients with acute or chronic renal insufficiency, are based in opinion; not prospective, experimental evidence." @Wagner_Nephro #MRI #Gadolinium #RSNA19https://t.co/hQ6tRWHlmN— Gadolinium Toxic (@GadoliniumToxic) December 2, 2019
Thursday, December 5, 2019
Gadolinium
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Feel free to leave comments. Have a great day in the Universe!